Home/Filings/4/0001628280-21-005661
4//SEC Filing

Cadavid Diego 4

Accession 0001628280-21-005661

CIK 0001501697other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 4:56 PM ET

Size

5.3 KB

Accession

0001628280-21-005661

Insider Transaction Report

Form 4
Period: 2021-03-24
Cadavid Diego
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-03-24+8,0358,035 total
Footnotes (2)
  • [F1]Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in three equal annual installments on February 11, 2022, February 11, 2023 and February 11, 2024 subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.
  • [F2]Represents unvested restricted stock units.

Issuer

X4 Pharmaceuticals, Inc

CIK 0001501697

Entity typeother

Related Parties

1
  • filerCIK 0001778713

Filing Metadata

Form type
4
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:56 PM ET
Size
5.3 KB